Top

European Archives of Psychiatry and Clinical Neuroscience

Published in:

01-06-2008 | STUDY BASED DISCUSSION

Kraepelin and psychotic prodromal conditions

Authors: Joachim Klosterkötter, Dr. Frauke Schultze-Lutter, Dr. Stephan Ruhrmann

Published in: European Archives of Psychiatry and Clinical Neuroscience | Special Issue 2/2008

Abstract

When Emil Kraepelin combined the formerly distinct entities of dementia paranoides, catatonia and hebephrenia to form the concept of ‘dementia praecox’ in 1896, he was well aware that this new disease entity—first coined ‘schizophrenia’ by Eugen Bleuler in 1908—does not generally only start off with the first psychotic manifestation. Even in his original observations, the characteristic psychotic phenomena developed via transition sequences from rather uncharacteristic prodromal disturbances. Meanwhile an initial prodromal condition was shown for about 75% of first-episode psychosis patients, lasting 5 years on average, possessing pathological significance and leading to psychosocial disruptions. Whereas most symptoms of the initial prodromal condition appear to be rather unspecific and hard to distinguish from other psychiatric conditions especially depressive ones, some syndromes seem to enable an early detection and thus an indicated prevention. These are constituted by attenuated and/or transient psychotic symptoms on the one hand and certain cognitive-perceptive basic symptoms on the other. Whereas the former are thought to delineate an advanced prodromal state, the latter can occur early in course and even at the beginning of the transition sequence to first-rank symptoms. This review will outline the current state of the art of a phase specific early detection and intervention based on these syndromes.

Addington D, Addington J, Patten S (1998) Depression in people with first-episode schizophrenia. Br J Psychiatry 172(Suppl 33):90–92

Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R (2007) North American Prodrome Longitudinal Study North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull 33(3):665–672PubMedCrossRef

American Psychiatric Association (APA) (1987) Diagnostic and statistical manual of mental disorders, 3rd revised edn. DSM-III-R. APA, Washington

American Psychiatric Association (APA) (1994) Diagnostic and statistical manual of mental disorders, 4th edn. DSM-IV. APA, Washington

Andreasen NC, Flaum M (1991) The characteristic symptoms. Schizophr Bull 17:27–49PubMed

Angermeyer MC, Matschinger H (2004) The stereotype of Schizophrenia and its impact on discrimination against people with Schizophrenia: results from a representative survey in Germany. Schizophr Bull 30(4):1049–1061PubMed

Bechdolf A, Wagner M, Hambrecht M (2002) Psychological intervention in the pre-psychotic phase: preliminary results of a multicentre trial. Acta Psychiatr Scand 106(Suppl 413):41

Bechdolf A, Veith V, Schwarzer D, Schormann M, Stamm E, Janssen B, Berning J, Wagner M, Klosterkötter J (2005a) Cognitive-behavioral therapy in the pre-psychotic phase: an exploratory study. Psychiatry Res 136(2–3):251–255PubMedCrossRef

Bechdolf A, Ruhrmann S, Wagner M, Kühn KU, Janssen B, Bottlender R, Wieneke A, Schulze-Lutter F, Maier W, Klosterkötter J (2005b) Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment. Br J Psychiatry 48(Suppl):S45–S48CrossRef

10.

Bechdolf A, Phillips LJ, Francey SM, Leicester S, Morrison AP, Veith V, Klosterkötter J, McGorry PD (2006) Recent approaches to psychological interventions for people at risk of psychosis. Eur Arch Psychiatry Clin Neurosci 256(3):159–173PubMedCrossRef

11.

Berger GE, Smesny S, Amminger GP (2006) Bioactive lipids in schizophrenia. Int Rev Psychiatry 18(2):85–98PubMedCrossRef

12.

Birchwood M, McMillan JF (1993) Early intervention in schizophrenia. Aust N Z J Psychiatry 27:374–378PubMedCrossRef

13.

Bleuler E (1911) Dementia praecox oder Gruppe der Schizophrenie. In: Aschaffenburg G (ed) Handbuch der Psychiatrie, 4. Abtlg, 1. Hälfte. Deuticke, Leipzig

14.

Brown S, Birtwistle J (1998) People with schizophrenia and their families. Fifteen-year outcome. Br J Psychiatry 173:139–144PubMed

15.

Cornblatt B, Obuchowski M, Roberts S, Pollack S, Erlenmeyer-Kimling L (1999) Cognitive and behavioural precursors of schizophrenia. Dev Psychopathol 11:487–508PubMedCrossRef

16.

Eastvold AD, Heaton RK, Cadenhead KS (2007) Neurocognitive deficits in the (putative) prodrome and first episode of psychosis. Schizophr Res 93(1–3):266–77PubMedCrossRef

17.

Gross G, Huber G, Klosterkötter J, Linz M (1987) Bonner Skala für die Beurteilung von Basissymptomen (BSABS: Bonn Scale for the Assessment of Basic Symptoms). Springer, Berlin

18.

Haas GL, Garratt LS, Sweeney JA (1998) Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness. J Psychiatr Res 32:151–159PubMedCrossRef

19.

Häfner H, Nowotny B, Löffler W, an der Heiden W, Maurer K (1995) When and how does schizophrenia produce social deficits? Eur Arch Psychiatry Clin Neurosci 246:17–28PubMedCrossRef

20.

Häfner H, Maurer K, Löffler W, an der Heiden W, Könnecke R, Hambrecht M (2002) The early course of schizophrenia. In: Häfner H (ed) Risk and protective factors in schizophrenia—towards a conceptual model of the disease process. Steinkopff, Darmstadt, pp 207–228

21.

Häfner H, Maurer K, Löffler W, an der Heiden W, Hambrecht M, Schultze-Lutter F (2003) Modeling the early course of schizophrenia. Schizophr Bull 29(2):325–340PubMed

22.

Häfner H, Maurer K, Ruhrmann S, Bechdolf A, Klosterkötter J, Wagner M, Maier W, Bottlender R, Möller HJ, Gaebel W, Wölwer W (2004) Early detection and secondary prevention of psychosis: facts and visions. Eur Arch Psychiatry Clin Neurosci 254(2):117–128PubMedCrossRef

23.

Hambrecht M, Häfner H (1996) Substance abuse and the onset of schizophrenia. Biol Psychiatry 39:1–9CrossRef

24.

Helgason L (1990) Twenty years’ follow-up of first psychiatric presentation for schizophrenia: What could have been prevented? Acta Psychiatr Scand 81:231–235PubMedCrossRef

25.

Huber G (1966) Reine Defektsyndrome und Basisstadien endogener Psychosen. Fortschr Neurol Psychiatr 34:409–426

26.

Huber G (1986) Psychiatrische Aspekte des Basisstörungskonzepts. In: Süllwold L, Huber G (eds) Schizophrene Basisstörungen. Springer, Berlin, pp 39–143

27.

Huber G, Gross G, Schüttler R (1979) Schizophrenie. Verlaufsund sozialpsychiatrische Langzeituntersuchungen an den 1945–1959 in Bonn hospitalisierten schizophrenen Kranken. Springer, Berlin

28.

Humphreys MS, Johnstone EC, MacMillan JF, Taylor PJ (1992) Dangerous behaviour preceding first admissions for schizophrenia. Br J Psychiatry 161:501–505PubMed

29.

Jackson HJ, McGorry PD, McKenzie D (1994) Prodromal symptoms of schizophrenia in first-episode psychosis. Prevalence and specificity. Compr Psychiatry 36:241–250CrossRef

30.

Jackson HJ, McGorry PD, Dakis J, Harrigan S, Henry L, Mihalopoulos C (1996) The inter-rater and test-retest reliabilities of prodromal symptoms in first-episode psychosis. Aust N Z J Psychiatry 30:498–504PubMedCrossRef

31.

Jaeschko R, Guyatt GH, Sackett DL (1994) User’s guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? JAMA 271:703–707CrossRef

32.

Johnstone EC, Crow TJ, Johnson AL, McMillan JF (1986) The Northwick Park study of first episodes of schizophrenia: I. Presentation of the illness and problems relating to admission. Br J Psychiatry 148:115–120PubMedCrossRef

33.

Johnstone EC, Macmillan JF, Frith CD, Benn DK, Crow TJ (1990) Further investigation of the predictors of outcome following first schizophrenic episodes. Br J Psychiatry 157:182–189PubMed

34.

Keefe RS, Perkins DO, Gu H, Zipursky RB, Christensen BK, Lieberman JA (2006) A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophr Res 88(1–3):26–35PubMedCrossRef

35.

Keshavan MS, Haas G, Miewald J, Montrose DM, Reddy R, Schooler NR, Sweeney JA (2003) Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr Bull 29:757–769PubMed

36.

Klosterkötter J (1992) The meaning of basic symptoms for the development of schizophrenic psychoses. Neurol Psychiatry Brain Res 1:30–41

37.

Klosterkötter J, Ebel H, Schultze-Lutter F, Steinmeyer EM (1996) Diagnostic validity of basic symptoms. Eur Arch Psychiatry Clin Neurosc 246:147–154CrossRef

38.

Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F (2001) Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 58:158–164PubMedCrossRef

39.

Klosterkötter J (2002) Predicting the onset of schizophrenia. In: Häfner H (ed) Risk and protective factors in schizophrenia—towards a conceptual model of the disease process. Steinkopff, Darmstadt pp 193–206

40.

Klosterkötter J, Ruhrmann S, Schultze-Lutter F, Salokangas RKR, Linszen D, Birchwood M, Juckel G, Morrison AP, Vázquèz-Barquero JL, Hambrecht M, Graf von Reventlow H, the EPOS group (2005) The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry 4(3):161–167PubMed

41.

Köhn D, Klosterkötter J (2003) Awareness-Programm: öffentlichkeitskampagne über Risikofaktoren, Frühsymptome und Frühbehandlung schizophrener Psychosen. In: Heinze M (ed) Früherkennung und Frühintervention bei schizophrenen Psychosen. be.bra wissenschaft, Berlin, pp 21–29

42.

Koreen AR, Siris SG, Chakos M, Alvir J, Mayerhoff D, Lieberman J (1993) Depression in first-episode schizophrenia. Am J Psychiatry 150:1643–1648PubMed

43.

Kraepelin E (1896) Psychiatrie - Ein Lehrbuch für Studierende und Ärzte (5. Aufl.). A. Barth, Leipzig

44.

Kraepelin E (1909) Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. Achte, vollständig umgearbeitete Auflage. I. Band. Allgemeine Psychiatrie. Barth Verlag, Leipzig

45.

Larsen TK, McGlashan TH, Moe LC (1996) First-episode schizophrenia: I. Early course parameters. Schizophr Bull 22:241–256PubMed

46.

Larsen TK, Johannessen JO, Opjordsmoen S (1998) First-episode schizophrenia with long duration of untreated psychosis. Pathways to care. Br J Psychiatry 172(Suppl 33):S45–S52

47.

Lieberman JA, Kinon BJ, Loebel AD (1990) Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 16:97–110PubMed

48.

Lieberman JA, Sheitman BB, Kinon BJ (1997) Endogenous neurochemical sensitization in the pathophysiology of schizophrenia deficits and dysfunction in neural regulation and plasticity. Neuropsychopharmacology 17:205–229PubMedCrossRef

49.

Loebel AD, Lieberman JA, Alvir JM, Mayerhoff DI, Geisler SH, Szymanski SR (1992) Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 149:1183–1188PubMed

50.

Marshall M, Lewis SW, Lockwood A, Drake R, Jones P, Croudance T (2005) Association between duration of untreated psychosis and outcome in cohorts of first-episode patients. Arch Gen Psychiatry 62:975–983PubMedCrossRef

51.

Maurer K, Hörrmann F, Trendler G, Schmidt M, Häfner H (2006) Früherkennung des Psychoserisikos mit dem Early Recognition Inventory (ERIraos). Beschreibung des Verfahrens und erste Ergebnisse zur Reliabilität und Validität der Checkliste. Nervenheilkunde 1–2:11–16

52.

Mayer-Gross W (1932) Die Klinik. In: Bumke O (ed) Handbuch der Geisteskrankheiten. Fünfter Teil. Die Schizophrenie. Julius Springer, Berlin, pp 293–375

53.

McGlashan TH (2006) Is active psychosis neurotoxic? Schizophr Bull 32(4):609–613PubMedCrossRef

54.

McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW; Hawkins KA, Hoffmann RE, Preda A, Epstein I (2006) Randomized, double-blind trial of Olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 163:790–799PubMedCrossRef

55.

McGorry PD, Edwards J, Mihalopoulos SM (1996) EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 22:305–326PubMed

56.

McGorry PD, Edwards J (1997) Early psychosis training pack. Victoria Mill. Gardiner-Caldwell Communications, Australia

57.

McGorry PD, McKenzie D, Jackson HJ, Waddell F, Curry C (2000) Can we improve the diagnostic efficiency and predictive power of prodromal symptoms for schizophrenia? Schizophr Res 42:91–100PubMedCrossRef

58.

McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J; Adlard S, McDonald T, Blair A, Jackson H (2002) A randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 59:921–928PubMedCrossRef

59.

Miller TJ, McGlashan TH, Lifshey Rosen J, Somjee L, Markovich PJ, Stein K, Woods SW (2002) Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of Interrater reliability and predictive validity. Am J Psychiatry 159:863–865PubMedCrossRef

60.

Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, Parker S, Bentall RP (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk. Br J Psychiatry 185:291–297PubMedCrossRef

61.

Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, Yung AR, Bullmore ET, Brewer W, Soulsby B, Desmond P, McGuire P (2003) Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361:281–288PubMedCrossRef

62.

Peralta V, Cuesta MJ (1999) Diagnostic significance of Schneider’s first rank symptoms in schizophrenia. Comparative study between schizophrenic and non-schizophrenic psychotic disorders. Br J Psychiatry 174:243–248PubMed

63.

Phillips LJ, Yung A, McGorry PD (2000) Identification of young people at risk of psychosis: validation of the personal assessment and crisis evaluation clinic intake criteria. Aust N Z J Psychiatry 34(Suppl):S164–S169PubMedCrossRef

64.

Pukrop R, Schultze-Lutter F, Ruhrmann S, Brockhaus-Dumke A, Tendolkar I, Bechdolf A, Matuschek E, Klosterkötter J (2006) Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first and multiple episode schizophrenia. J Clin Exp Neuropsychol 28:1388– 1407PubMedCrossRef

65.

Pukrop R, Ruhrmann S, Schultze-Lutter F, Bechdolf A, Brockhaus-Dumke A, Klosterkötter J (2007) Neurocognitive indicators for a conversion to psychosis: Comparison of patients in a potentially prodromal state who did or did not convert to a psychosis. Schizophr Res 92(1–2):116–125PubMedCrossRef

66.

Ruhrmann S, Kühn KU, Streit M, Bottlender R, Maier W, Klosterkötter J (2002) Pharmakologische und psychologische Frühintervention bei Risikopersonen mit psychosenahen Prodromen: erste Ergebnisse einer kontrollierten Studie. Nervenarzt 73(Suppl.1):9

67.

Ruhrmann S, Schultze-Lutter F, Klosterkötter J (2003) Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry 36(Suppl 3):162–167

68.

Ruhrmann S, Bechdolf A, Kühn KU, Wagner M, Schultze-Lutter F, Janssen B, Gaebel W, Möller HJ, Maier W, Klosterkötter J for the LIPS study group (2008) Acute symptomatic treatment effects in persons putatively in a late initial prodromal state of psychosis. Br J Psychiatry (in press)

69.

Schimmelmann BG, Conus P, Cotton S, McGorry PD, Lambert M (2007) Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients. Schizophr Res 95(1–3):1–8PubMedCrossRef

70.

Schultze-Lutter F (2004) Prediction of psychosis is necessary and possible. In: McDonald C, Schultz K, Murray R, Wright P (eds) Schizophrenia: challenging the orthodox. Taylor & Francis, London, pp 81–90

71.

Schultze-Lutter F, Ruhrmann S, Klosterkötter J (2006) Can schizophrenia be predicted phenomenologically? In: Johannessen JO, Martindale B, Cullberg J (eds) Evolving psychosis. Different stages, different treatments. Routledge, London, pp 104–123

72.

Schultze-Lutter F, Addington J, Ruhrmann S, Klosterkötter J (2007a) Schizophrenia Proneness Instrument, Adult version (SPI-A). Giovanni Fioriti Editore s.r.l, Rome

73.

Schultze-Lutter F, Klosterkötter J, Picker H, Steinmeyer EM, Ruhrmann S (2007b) Predicting first-episode psychosis by basic symptom criteria. Clin Neuropsychiatry 4(1):11–22

74.

Schultze-Lutter F, Ruhrmann S, Picker H, Graf von Reventlow H, Hoppmann B, Brockhaus-Dumke A, Klosterkötter J, Pukrop R (2008) Relationship between subjective and objective cognitive function in the early and late prodrome. Br J Psychiatry (in press)

75.

Simon AE, Cattapan-Ludewig K, Zmilacher S, Arbach D, Gruber K, Dvorsky DN, Roth B, Isler E, Zimmer A, Umbricht D (2007) Cognitive functioning in the schizophrenia prodrome. Schizophr Bull 33(3):761–71PubMedCrossRef

76.

Stirling J et al (1991) Expressed emotion and early onset schizophrenia: a one-year follow-up. Psychol Med 21:675–685PubMed

77.

Stirling J, Tantam D, Thomas P, Newby D, Montague L, Ring N, Rowe S (1993) Expressed emotion and schizophrenia: the ontogeny of EE during an 18-month follow-up. Psychol Med 23:771–778PubMed

78.

Strakowski SM, Keck PE Jr, McElroy SL, Lonczak HS, West SA (1995) Chronology of comorbid and principal syndromes in first-episode psychosis. Compr Psychiatry 36:106–112PubMedCrossRef

79.

Verdoux H, Maurice-Tison S, Gay B, van Os J, Salamon R, Bourgeois ML (1998) A survey of delusional ideation in primary-care patients. Psychol Med 28:127–134PubMedCrossRef

80.

Wing JK, Cooper JF, Sartorius N (1974) Measurement and classification of psychiatric symptoms. An Introduction manual for PSE and Catego-program. Cambridge Press, London

81.

Wölwer W, Buchkremer G, Häfner H, Klosterkötter J, Maier W, Möller HJ, Gaebel W (2003) German research network on schizophrenia-bridging the gap between research and care. Eur Arch Psychiatry Clin Neurosci 253(6):321–329PubMedCrossRef

82.

Wyatt RJ (1991) Neuroleptics and the natural course of schizophrenia. Schizophr Bull 17:325–51PubMed

83.

Yung AR, McGorry PD (1996) The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 22:353–370PubMed

84.

Yung AR, Phillips LJ, Yuen HP, McGorry PD (2004) Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 67:131–142PubMedCrossRef

85.

Yung AR, Stanford C, Cosgrave E, Killackey E, Phillips LJ, Nelson B, McGorry PD (2006) Testing the ultra high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res 84:57–66PubMedCrossRef

86.

Yung AR, Killackey E, Hetrick SE, Parker AG, Schultze-Lutter F, Klosterkötter J, Purcell R, McGorry PD (2007) The prevention of schizophrenia. Int Rev Psychiatry 19(6):633–646PubMedCrossRef

Title: Kraepelin and psychotic prodromal conditions
Authors: Joachim Klosterkötter
Dr. Frauke Schultze-Lutter
Dr. Stephan Ruhrmann
Publication date: 01-06-2008
Publisher: D. Steinkopff-Verlag
Published in: European Archives of Psychiatry and Clinical Neuroscience / Issue Special Issue 2/2008
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-008-2010-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Kraepelin and psychotic prodromal conditions

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2008

Kraepelin, biological psychiatry, and beyond

Evidence for separate diseases?

Diagnosis and course of affective psychoses: was Kraepelin right?

Emil Kraepelin’s legacy: systematic clinical observation and the categorical classification of psychiatric diseases

Multifactorial inheritance, rates of maturation and psychiatry’s taxonomic dilemma

A psychoneuroimmunological perspective to Emil Kraepelins dichotomy